Is EASTON PHARMACEUTICA (OTCMKTS:EAPH) a Buy? The Stock Reported Less Sellers – Finance News Daily

December 10, 2017 – By Vivian Park

The stock of EASTON PHARMACEUTICA (OTCMKTS:EAPH) registered a decrease of 53.21% in short interest. EAPH’s total short interest was 21,900 shares in December as published by FINRA. Its down 53.21% from 46,800 shares, reported previously.

The stock increased 0.73% or $0.00015 during the last trading session, reaching $0.02075. About 861,026 shares traded. Easton Pharmaceuticals Inc. (OTCMKTS:EAPH) has 0.00% since December 10, 2016 and is . It has underperformed by 16.70% the S&P500.

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. The company has market cap of $23.89 million. The Company’s products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. It currently has negative earnings. The firm is also developing XILIVE, an early stage cancer drug.


Read More Here...

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Trackbacks are closed, but you can post a comment.